TOC

July 1, 2005

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-07-01-2005, Volume 0, Issue 0

What Pharma Wants From IT Today

What Pharma Wants From IT Today

Ellen Julian

Life Science Insights

See results from the 2005 Pharmaceutical Executive/Life Science Insights Information Technology Survey.

Research

Informatics Rules

MaryJo Zaborowski, Juergen Hammer, and Gloria Lawler

Roche

Roche's Global Research Informatics organization, formed to facilitate data sharing, is helping to put the company's global network of scientists on the same page.

Compliance

The Source of Truth

Patrick Clinton

Editor-in-Chief

IT solutions for ensuring compliance are top of mind for pharma execs—and the technology vendors that supply them.

Case Study

In Search of the Holy Grail

Rob Case

Procter & Gamble Pharmaceuticals

Data integration is improving overall clinical trials management, but quantifying ROI remains a ways off.

Outsourcing

Shedding Wings

In this Q&A, Pharm Exec talks to John Hagel about his latest book, and about why he thinks outsourcing decisions should be driven by quality improvement—not cost reduction.

News & Analysis

Leading Indicators

News

GSK's new facility to focus on external drug discovery programs » Medsite's new partnership with Yahoo! » Legislators support FDA's authority to make post-marketing labeling changes. » Tension heightens between PBMs and pharmacists.

Data

Compliance especially important for diabetics » Trust in online health information on the rise.

Thought Leaders

At the helm of Sirius Laboratories, Garry Barnes preaches specialty sales force excellence.

Washington Report

The e-precribing bandwagon is filling up fast.

Jill Wechsler

Global Report

Industry and pharmaceutical wholesalers are both holding out for a ruling on parallel trade in Europe—just not the same one.

Sarah Houlton

Leadership

Leaders today must do more than just keep ahead of trends—they must set them.

Sander A. Flaum

Flaum Partners

Legal Forum

If you provide misleading information and an investor loses, are you to blame?

Pamela Palmer and Jeff Hammel

Latham & Watkins

Strategy & Tactics

Direct to Consumer

To regain trust, pharma must invest further in connecting corporate brands more directly with product brands.

Ken Dec

PreVision

Marketing to Professionals

The government plans to link clinical trial evidence with real-world drug applications, says one member of the Medicare Coverage Advisory Committee.

Bryan Luce

United BioSource Corporation

Alternative Media

Perks are in store for pharma companies that jump on the expanding medium of health information portals.

Debrianna Obara

Avenue A/Razorfish

Sales Management

Incentive management helped Wyeth align its reps' rewards with sales strategies after undergoing a merger.

Mark Stiffler

Synergy

Insights

From the Editor

The push to ban ED drugs from Medicare reimbursement isn't about their "lifestyle" classification.

Patrick Clinton

Editor-in-Chief

Back Page

Pharma has more in common with tobacco than it may think.

Sarah Wealleans

Landor Associates

Resources

People Update

Calendar of Events

Advertisers Index